Efficacy of preoperative albendazole use according to months in hydatid cyst of the liver

Journal of Clinical Gastroenterology

Volumn 41, Issue 3, 2007, Pages 312-316

  Bildik, Nejdet ^a   Çevik, Ayhan ^a   Altintaş, Mehmet ^a   Ekinci, Hüseyin ^a   Canberk, Mustafa ^a   Gülmen, Mustafa ^a  

^a DR LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Albendazole; Hepatic hydatid cyst; Surgery

Indexed keywords

ALBENDAZOLE;

ADULT; ANOREXIA; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EPIGASTRIC PAIN; FEMALE; HUMAN; LIVER HYDATID CYST; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ALBENDAZOLE; ANIMALS; ANTICESTODAL AGENTS; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS GRANULOSUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 33847354748     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225572.50514.e6     Document Type: Article

References (16)

1. Altintaş K. İnsan saǧliǧi yönünden ekinokokkozun Türkiye'de ve Dünya daki epidemiyolojisi ve proflaksisi. Cerrahi Türkiye Klinikleri Nobel Tip Kitabevi Ïstanbul. 1998;3:182-186.
2. Menteş A. Hydatid liver disease. A perspective in treatment. Dig Dis. 1994;12:150-160.
3. Republic of Turkey Health Ministry Statistics A lists 2003;40:122.
4. Schantz PM, Schwabe C. Worldwide status of hydatid disease control. JAVA. 1999;12:2104-2118.
5. Bozkurt B, Soran A, Karabeyoglu M, et al. Follow-up problems and changes in obliteration of the residual cystic cavity after treatment for hepatic hydatidosis. J Hepatobiliary Pancreat Surg. 2003;10:441-445.
6. Sayek I, Tirnaksiz MB, Dogan R. Cystic hydatid disease: current trends in diagnosis and management. Surg Today. 2004;34:987-996.
7. Morris DL. Preoperative albendazole therapy for hydatid cysts. Br J Surg. 1997;74:805-806.
8. Guermouche S, Guermouche MH, Belkaid M, et al. High performance liquid chromatography study of albendazole sulfoxide distribution in plasma and cyst liquid during hydatidosis treatment. Ann Pharm F. 2002;46:15-18.
9. Senyuz OF, Yesildag E, Celayir S. Albendazole therapy in the treatment of hydatid liver disease. Surg Today. 2001;31:487-491.
10. Güngör Ç, Altintaş K. Evaluation of indirect hemaglutinotion latex aglutination and indirect fluorescent antibody techniques in diagnosis. Acta Paras Tur. 1990;14:61-68.
11. Yalin R, Aktan Ö, Yeǧen L, et al. The significance of intracystic pressure to abdominal hydatid cysts. Br J Surg. 1992;78:1182-1183.
12. Morris DL, Chinnery JB, Georgiou G, et al. Penetration albendazole sulphoxide into hydatid cysts. Gut. 1997;28:75-80.
13. Hortan RJ. Chemotherapy of echinococcus infection in man with albendazole. Trans Roy Soc Trop Med Hyg. 2002;83:97-102.
14. Aktan Ö, Yalin R. Propertive albendazole treatment for liver hydatid disease decreases the viability of cyst. Eur J Gastroenterol Hepatol. 1996;8:977-979.
15. Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg. 2004;28:731-736.
16. Karaoglanoglu M, Akinci OF, Bozkurt S, et al. Effect of different pharmacologic and chemical agents on the integrity of hydatid cyst membranes. AJR Am J Roentgenol. 2004;183:465-469.